DOT Diary Mobile App for Pre-Exposure Prophylaxis Adherence in Young Men
Status:
Completed
Trial end date:
2020-04-21
Target enrollment:
Participant gender:
Summary
The researchers are working with a technology company, AiCure, to develop a smartphone app,
DOT Diary, which combines two drug adherence strategies. DOT Diary reminds people when it is
time to take their medication, and uses motion-sensing technology to visually and
automatically confirm the pill was swallowed. The goal of this study is to assess the impact
of the app on adherence to HIV pre-exposure prophylaxis (PrEP) for the prevention of HIV.
Phase:
Phase 4
Details
Lead Sponsor:
Public Health Foundation Enterprises, Inc.
Collaborators:
AiCure Emory University National Institute of Allergy and Infectious Diseases (NIAID) National Institute of Mental Health (NIMH) San Francisco Department of Public Health
Treatments:
Emtricitabine Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination Tenofovir